NovaBay Pharmaceuticals Inc (NBY)
0.718
+0.01
(+1.27%)
USD |
NYAM |
Nov 21, 16:00
0.7093
-0.01
(-1.21%)
After-Hours: 20:00
NovaBay Pharmaceuticals Enterprise Value: 2.745M for Nov. 20, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 20, 2024 | 2.745M |
| November 19, 2024 | 2.698M |
| November 18, 2024 | 2.70M |
| November 15, 2024 | 2.764M |
| November 14, 2024 | 2.833M |
| November 13, 2024 | 2.762M |
| November 12, 2024 | 3.092M |
| November 11, 2024 | 2.726M |
| November 08, 2024 | 2.673M |
| November 07, 2024 | 2.696M |
| November 06, 2024 | 2.774M |
| November 05, 2024 | 2.970M |
| November 04, 2024 | 2.975M |
| November 01, 2024 | 2.945M |
| October 31, 2024 | 2.779M |
| October 30, 2024 | 2.957M |
| October 29, 2024 | 2.461M |
| October 28, 2024 | 1.970M |
| October 25, 2024 | 1.973M |
| October 24, 2024 | 2.046M |
| October 23, 2024 | 2.185M |
| October 22, 2024 | 2.168M |
| October 21, 2024 | 2.316M |
| October 18, 2024 | 2.358M |
| October 17, 2024 | 2.164M |
| Date | Value |
|---|---|
| October 16, 2024 | 2.164M |
| October 15, 2024 | 2.247M |
| October 14, 2024 | 2.286M |
| October 11, 2024 | 2.325M |
| October 10, 2024 | 2.334M |
| October 09, 2024 | 2.471M |
| October 08, 2024 | 2.621M |
| October 07, 2024 | 2.667M |
| October 04, 2024 | 2.750M |
| October 03, 2024 | 2.893M |
| October 02, 2024 | 2.681M |
| October 01, 2024 | 2.595M |
| September 30, 2024 | 2.648M |
| September 27, 2024 | 3.420M |
| September 26, 2024 | 3.518M |
| September 25, 2024 | 3.322M |
| September 24, 2024 | 3.395M |
| September 23, 2024 | 3.601M |
| September 20, 2024 | 3.566M |
| September 19, 2024 | 2.379M |
| September 18, 2024 | 2.443M |
| September 17, 2024 | 2.540M |
| September 16, 2024 | 2.338M |
| September 13, 2024 | 2.271M |
| September 12, 2024 | 2.257M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-0.9342M
Minimum
Dec 27 2022
51.06M
Maximum
Aug 04 2020
10.68M
Average
7.788M
Median
Enterprise Value Benchmarks
| Palatin Technologies Inc | 15.49M |
| iBio Inc | 9.932M |
| Theriva Biologics Inc | -12.74M |
| Oragenics Inc | 2.485M |
| Nanoviricides Inc | 15.22M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -1.212M |
| Revenue (Quarterly) | 2.441M |
| Total Expenses (Quarterly) | 3.502M |
| EPS Diluted (Quarterly) | -0.60 |
| Gross Profit Margin (Quarterly) | 65.26% |
| Profit Margin (Quarterly) | -49.65% |
| Earnings Yield | -4.99K% |
| Normalized Earnings Yield | -3568.95 |